MUMBAI, India, November 30, 2012 /PRNewswire/ --
SIRO Clinpharm, a leading full service Clinical Research Organization, announced the deployment of one of the biggest IT advancement projects in the region - Oracle Health Sciences InForm - an integrated life sciences solution with all the tools required to efficiently conduct and manage EDC-based clinical trials.
The application of Oracle Health Sciences InForm enables SIRO to automate and streamline solutions for the global biopharma and medical devices companies in their clinical development process across therapeutic areas and phases. With a breadth of services encompassing clinical operations, clinical data management, medical writing, biostatistics and statistical programming, pharmacovigilance and clinical trial supplies management, this comes as a huge step toward adopting global trial processes, as EDC systems are widely used across Western Europe and the United States.
"Our IT capabilities in the region are second to none. By deploying Oracle Health Sciences InForm, we have upgraded our technology platforms to global standards. Combined with our expertise in clinical development, we can now offer our clients a very effective and seamless user experience," said Khushru Patel, Global Head, Information Technology. "The software's flexibility, scalability and real-time access to trial data streamline and accelerate large and complex international trials.""We help our clients take advantage of technology developments to tackle dynamic regulatory environments, escalating disease complications and fierce competition to get products to the market," said Gopakumar Menon, CEO. About SIRO Clinpharm: SIRO Clinpharm, winner of Frost & Sullivan ' Clinical Research Organization of the year 2012 ' India Healthcare Award, is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in clinical data management, medical writing, biostatistics, clinical trial management and clinical trial supplies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious diseases & respiratory disorders. We offer flexible business models across service verticals based on client needs.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV